ReviewHuman vaccines & immunotherapeutics2020

Potential for developing a SARS-CoV receptor-binding domain (RBD) recombinant protein as a heterologous human vaccine against coronavirus infectious disease (COVID)-19.

Wen-Hsiang Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.